August 11, 2022

Provider Education Seminar Series to host third seminar

The HPV Roundtable’s third seminar of the Provider Education Seminar Series is “Effective Communication Strategies and Techniques for HPV Vaccination.” It will be August 11 from noon to 1 pm. Speakers will provide relevant approaches in ways to communicate that help to increase HPV vaccinations in clinic and in the community.

To receive more information, email PreventHPV@stjude.org.

logo for  HPV Roundtable Memphis and Shelby
September 28-29, 2022

National HPV Vaccination Roundtable Meeting 

Step up to the plate and vax like a champion at the National HPV Vaccination Roundtable 2022 National Meeting. Make plans to attend September 28–29. The event will feature an all-star lineup of inspiring speakers to help your team improve HPV vaccination. Join virtually from anywhere in the world. It’s free to attend.  Join the National HPV Vaccination Roundtable’s mailing list to get into the starting lineup.

4-part virtual seminar series

Accessing Implementation Science in Action and Research Opportunities on HPV Cancer Prevention Materials

“Implementation Science in Action and Research Opportunities on HPV Cancer Prevention” was a 4-part virtual seminar series. This series was presented by the HPV Research Group of the St. Jude and Washington University in St. Louis Implementation Sciences Collaborative.

During the final virtual seminar, preliminary results from a systematic review of HPV vaccination intervention research contexts was reported. Most intervention research has been conducted in clinical settings. However, growing vaccination hesitancy demands more attention on intervention efforts to increase HPV vaccination confidence in a range of contexts. Few studies looked at the urgency of increasing HPV vaccination interventions with populations experiencing inequities.

Limited implementation science research on HPV vaccination has been published, thus, the review was limited to intervention implementation more broadly. Results point to important gaps in HPV vaccination intervention research, including a need for more research addressing community and policy settings. It also shows a need for a greater focus on groups that experience health inequities.

Following this, speakers shared a portfolio analysis of National Cancer Institute (NCI)-funded research from fiscal years 2006–21. Results show an increase in HPV vaccinations with a common focus on clinical settings and health care providers. Future analyses may be directed to focus on rural populations and other populations.

The final segment provided a recap of the community, clinical, and policy contexts explored in previous seminars. HPV vaccination research priorities were captured during the virtual seminar. If you could not attend but would like to contribute, submit your feedback about research priorities in this survey. You may also share this link with others who may want to provide input.